Tumor treating field plus chemotherapy for locally advanced pancreatic adenocarcinoma: An international cost-effectiveness analysis.

Sci Rep · 2026 · PMC13433937 · PMID 42185415

Europe PMC DOI

hedged sentence

0.1370

closest p · 2.7× alpha

0.1370

boldest claim

The sentences

a favorable trendP = 0.137not close (p > 0.1)

14.2 months; hazard ratio [HR]: 0.82; 95% confidence interval [CI]: 0.68-0.99; P = 0.039), with a favorable trend observed for progression-free survival (PFS) as well (median PFS: 10.6 vs. 9.3 months; HR: 0.85; 95% CI: 0.68-1.05; P = 0.137) 12 .

also in 1,335 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.